ERYTECH Pharma S.A.

ERYTECH Pharma S.A.verified

ERYP

Price:

$0.78

Market Cap:

$43.56M

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.[Read more]

Industry

Biotechnology

IPO Date

2016-07-05

Stock Exchange

NASDAQ

Ticker

ERYP

The Enterprise Value as of November 2024 (TTM) for ERYTECH Pharma S.A. (ERYP) is 43.56M

According to ERYTECH Pharma S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 43.56M. This represents a change of -650.75% compared to the average of -7909219.68 of the last 4 quarters.

ERYTECH Pharma S.A. (ERYP) Historical Enterprise Value (quarterly & annually)

How has ERYP Enterprise Value performed in the past?

The mean historical Enterprise Value of ERYTECH Pharma S.A. over the last ten years is 73.74M. The current 43.56M Enterprise Value has changed 5.81% with respect to the historical average. Over the past ten years (40 quarters), ERYP's Enterprise Value was at its highest in in the December 2020 quarter at 118.43M. The Enterprise Value was at its lowest in in the December 2017 quarter at -182680000.00.

Quarterly (TTM)
Annual

Average

73.74M

Median

75.60M

Minimum

-26436734.61

Maximum

149.42M

ERYTECH Pharma S.A. (ERYP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ERYTECH Pharma S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 108.28%

Maximum Annual Enterprise Value = 149.42M

Minimum Annual Increase = -321.25%

Minimum Annual Enterprise Value = -26436734.61

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022-15625548.53-138.26%
202140.84M-66.48%
2020121.82M108.28%
201958.49M-321.25%
2018-26436734.61-118.06%
2017146.34M-2.06%
2016149.42M34.22%
2015111.33M35.46%
201482.18M19.08%
201369.01M-34.62%

ERYTECH Pharma S.A. (ERYP) Average Enterprise Value

How has ERYP Enterprise Value performed in the past?

The current Enterprise Value of ERYTECH Pharma S.A. (ERYP) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

49.01M

5-year avg

35.82M

10-year avg

73.74M

ERYTECH Pharma S.A. (ERYP) Enterprise Value vs. Peers

How is ERYP’s Enterprise Value compared to its peers?

ERYTECH Pharma S.A.’s Enterprise Value is less than Genfit S.A. (264.28M), greater than Cyteir Therapeutics, Inc. (-20511738.00), less than Eliem Therapeutics, Inc. (119.64M), greater than HCW Biologics Inc. (25.13M), greater than Aptorum Group Limited (8.77M), greater than Surrozen, Inc. (2.49M), less than Unicycive Therapeutics, Inc. (50.32M), less than Armata Pharmaceuticals, Inc. (204.77M), greater than Addex Therapeutics Ltd (11.85M), greater than Aceragen, Inc. (-8243034.00), greater than Soligenix, Inc. (1.83M), greater than Avenue Therapeutics, Inc. (-1770008.00), less than Molecular Partners AG (0), less than XORTX Therapeutics Inc. (57.66M), greater than Nutriband Inc. (2.02M), less than Ikena Oncology, Inc. (57.98M), less than Enochian Biosciences, Inc. (47.83M), less than Exicure, Inc. (102.45M), greater than null (11.91M),

Build a custom stock screener for ERYTECH Pharma S.A. (ERYP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ERYTECH Pharma S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ERYTECH Pharma S.A. (ERYP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ERYTECH Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ERYTECH Pharma S.A.'s Enterprise Value?

What is the highest Enterprise Value for ERYTECH Pharma S.A. (ERYP)?

What is the 3-year average Enterprise Value for ERYTECH Pharma S.A. (ERYP)?

What is the 5-year average Enterprise Value for ERYTECH Pharma S.A. (ERYP)?

How does the current Enterprise Value for ERYTECH Pharma S.A. (ERYP) compare to its historical average?